Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic

Pulm Circ. 2020 Sep 16;10(3):2045894020948783. doi: 10.1177/2045894020948783. eCollection 2020 Jul-Sep.

Abstract

Right heart catheterization is an essential diagnostic modality in the evaluation of pulmonary hypertension. The coronavirus disease 2019 pandemic has resulted in deferral of elective procedures including right heart catheterization. The benefits of proceeding with right heart catheterization, such as further characterization of hemodynamic subtype and severity of pulmonary hypertension, initiation of targeted pulmonary arterial hypertension therapy, as well as further hemodynamic testing, need to be carefully balanced with the risk of potentially exposing both patients and health care personnel to coronavirus disease 2019 infection. This review article aims to provide best clinical practices for safely performing right heart catheterization in pulmonary hypertension patients during the coronavirus disease 2019 pandemic.

Keywords: COVID-19; coronavirus; infection prevention; pulmonary hypertension; right heart catheterization.

Publication types

  • Review